Ameliorative action of "daitongxiao" against hyperuricemia includes the "uric acid transporter group" by Lijie Zheng, Yuanmei Bai, Yan Wan, Feifan Liu, Yuhuan Xie, Jinglin He, Peixin Guo

Connect to this object online.

Mechanisms of Yajieshaba in the treatment of liver fibrosis through the Keap1-Nrf2 signaling pathway by Yuanmei Bai, Haimei Wu, Lijie Zheng, Yuhuan Xie, Feifan Liu, Yan Wan, Qiongchao Li, Peixin Guo

Connect to this object online.

DaiTongXiao improves gout nephropathy by inhibiting inflammatory response through the TLR4/MyD88/NF-κB pathway by Feifan Liu, Yuanmei Bai, Yan Wan, Shifang Luo, Linao Zhang, Xue Wu, Rong Chen, Zili Yin, Yuhuan Xie, Peixin Guo

Connect to this object online.

Correction: Clinical, social, and policy factors in COVID-19 cases and deaths: methodological considerations for feature selection and modeling in county-level analyses by Charisse Madlock-Brown, Ken Wilkens, Nicole Weiskopf, Nina Cesare, Sharmodeep Bhattacharyya, Naomi O. Riches, Juan Espinoza, David Dorr, Kerry Goetz, Jimmy Phuong, Anupam Sule, Hadi Kharrazi, Feifan Liu, Cindy Lemon, William G. Adams

Connect to this object online.

Clinical, social, and policy factors in COVID-19 cases and deaths: methodological considerations for feature selection and modeling in county-level analyses by Charisse Madlock-Brown, Ken Wilkens, Nicole Weiskopf, Nina Cesare, Sharmodeep Bhattacharyya, Naomi O. Riches, Juan Espinoza, David Dorr, Kerry Goetz, Jimmy Phuong, Anupam Sule, Hadi Kharrazi, Feifan Liu, Cindy Lemon, William G. Adams

Connect to this object online.